Diffuse Large B Cell Lymphoma
Showing 26 - 50 of 206
Large B-cell Lymphoma, Diffuse Large B Cell Lymphoma Trial in Homburg (R-miniCHOP + Acalabrutinib, R-miniCHOP)
Not yet recruiting
- Large B-cell Lymphoma
- Diffuse Large B Cell Lymphoma
- R-miniCHOP + Acalabrutinib
- R-miniCHOP
-
Homburg, Saarland, GermanySaarland University Medical Center
Apr 19, 2023
Diffuse Large B Cell Lymphoma Trial in Suzhou (Rituximab, Orelabrutinib, Pomalidomide)
Recruiting
- Diffuse Large B Cell Lymphoma
- Rituximab
- +4 more
-
Suzhou, Jiangsu, Chinathe First Affiliated Hospital of Soochow University
Apr 10, 2023
Diffuse Large B Cell Lymphoma Trial in Tampa (Itacitinib, Chimeric antigen receptor (CAR) T-cell therapy)
Recruiting
- Diffuse Large B Cell Lymphoma
- Itacitinib
- Chimeric antigen receptor (CAR) T-cell therapy
-
Tampa, FloridaMoffitt Cancer Center
Mar 6, 2023
Including miRNA-based Tumor Signatures in Diffuse Large B Cell
Not yet recruiting
- Diffuse Large B Cell Lymphoma
- Relapsed Non-Hodgkin Lymphoma
- no intervention (observational study)
-
Napoli, Italy
- +2 more
Feb 17, 2023
Diffuse Large B-Cell Lymphoma Patients Treated With CAR-T Cell
Not yet recruiting
- Diffuse Large B Cell Lymphoma
- Gut microbiome analysis
-
Bologna, ItalyInstitute Of Hematology "Seràgnoli"
Feb 10, 2023
Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Acute Lymphoblastic Leukemia Trial in Tampa (Fludarabine, Cyclophosphamide,
Recruiting
- Chronic Lymphocytic Leukemia
- +4 more
- Fludarabine
- +2 more
-
Tampa, FloridaMoffitt Cancer Center
Jan 12, 2023
Diffuse Large B Cell Lymphoma Trial (Epcoritamab, Lenalidomide)
Not yet recruiting
- Diffuse Large B Cell Lymphoma
- Epcoritamab
- Lenalidomide
- (no location specified)
Jan 20, 2023
Diffuse Large B Cell Lymphoma Trial in Worldwide (Tafasitamab, Lenalidomide)
Recruiting
- Diffuse Large B Cell Lymphoma
-
Dallas, Texas
- +29 more
Jan 20, 2023
Lymphoma, Non-Hodgkin, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial in New York (Venetoclax, Tazemetostat)
Not yet recruiting
- Lymphoma, Non-Hodgkin
- +2 more
-
New York, New YorkWeill Cornell Medicine/NewYork-Presberteryian Hospital
Jan 18, 2023
Axicabtagene Ciloleucel:Neurocognitive and Patient-Reported
Active, not recruiting
- Diffuse Large B Cell Lymphoma
- Transformed Lymphoma
- Handgrip strength test
- +9 more
-
Tampa, FloridaMoffitt Cancer Center
Jan 12, 2023
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Follicular Lymphoma Trial in Australia, China (BGB-10188,
Recruiting
- Chronic Lymphocytic Leukemia
- +9 more
- BGB-10188
- +2 more
-
Adelaide, Australia
- +12 more
Jan 6, 2023
Diffuse Large B Cell Lymphoma Trial in Rouen (CAR-T cells monitoring)
Not yet recruiting
- Diffuse Large B Cell Lymphoma
- CAR-T cells monitoring
-
Rouen, FranceCentre Henri Becquerel
Dec 22, 2022
Diffuse Large B Cell Lymphoma Trial (anti-CD19 CAR NK cells)
Not yet recruiting
- Diffuse Large B Cell Lymphoma
- anti-CD19 CAR NK cells
- (no location specified)
Dec 21, 2022
Diffuse Large B Cell Lymphoma Trial in Philadelphia (Nivolumab, IV, 240 mg)
Active, not recruiting
- Diffuse Large B Cell Lymphoma
- Nivolumab, IV, 240 mg
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Jan 3, 2023
B Cell Lymphoma, Aggressive Lymphoma, Diffuse Large B Cell Lymphoma Trial in Saint Louis (Mosunetuzumab)
Recruiting
- B Cell Lymphoma
- +5 more
-
Saint Louis, MissouriWashington University School of Medicine
Jan 3, 2023
Waldenstrom Macroglobulinemia, Multiple Myeloma, Chronic Lymphocytic Leukemia Trial in Worldwide (Iopofosine I 131 single dose,
Recruiting
- Waldenstrom Macroglobulinemia
- +8 more
- Iopofosine I 131 single dose
- +2 more
-
Redlands, California
- +42 more
Dec 30, 2022
Diffuse Large B Cell Lymphoma, DLBCL, Cancer Trial in Madison (Rituximab, Cyclophosphamide, Doxorubicin)
Recruiting
- Diffuse Large B Cell Lymphoma
- +2 more
- Rituximab
- +5 more
-
Madison, WisconsinUniversity of Wisconsin Carbone Cancer Center
Dec 12, 2022
Patients Previously Treated WithMustang Bio CAR-T Cell
Enrolling by invitation
- Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- +10 more
- Prior MB-102 CAR-T cell investigational product.
- Prior MB-106 CAR-T cell investigational product.
-
Duarte, California
- +4 more
Dec 8, 2022